Growth Metrics

KalVista Pharmaceuticals (KALV) Cash from Operations (2016 - 2025)

KalVista Pharmaceuticals' Cash from Operations history spans 10 years, with the latest figure at 40364000.0 for Q2 2025.

  • On a quarterly basis, Cash from Operations fell 167.22% to 40364000.0 in Q2 2025 year-over-year; TTM through Apr 2025 was 135331000.0, a 51.66% decrease, with the full-year FY2025 number at 152907000.0, down 71.36% from a year prior.
  • Cash from Operations hit 40364000.0 in Q2 2025 for KalVista Pharmaceuticals, down from 39642000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for KALV hit a ceiling of 15105000.0 in Q2 2024 and a floor of 40364000.0 in Q2 2025.
  • Historically, Cash from Operations has averaged 29922428.57 across 3 years, with a median of 27571000.0 in 2024.
  • Biggest five-year swings in Cash from Operations: tumbled 50.47% in 2024 and later plummeted 167.22% in 2025.
  • Tracing KALV's Cash from Operations over 3 years: stood at 19825000.0 in 2023, then plummeted by 99.96% to 39642000.0 in 2024, then decreased by 1.82% to 40364000.0 in 2025.
  • Business Quant data shows Cash from Operations for KALV at 40364000.0 in Q2 2025, 39642000.0 in Q4 2024, and 40220000.0 in Q3 2024.